These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

239 related items for PubMed ID: 17651311

  • 1. Paraoxonase phenotype distribution in a healthy Iranian population.
    Sepahvand F, Shafiei M, Ghaffari SM, Rahimi-Moghaddam P, Mahmoudian M.
    Basic Clin Pharmacol Toxicol; 2007 Aug; 101(2):104-7. PubMed ID: 17651311
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Frequency of paraoxonase 192/55 polymorphism in an Iranian population.
    Sepahvand F, Rahimi-Moghaddam P, Shafiei M, Ghaffari SM, Rostam-Shirazi M, Mahmoudian M.
    J Toxicol Environ Health A; 2007 Jul; 70(13):1125-9. PubMed ID: 17558807
    [Abstract] [Full Text] [Related]

  • 6. Serum paraoxonase phenotype distribution in exudative age-related macular degeneration and its relationship to homocysteine and oxidized low-density lipoprotein.
    Javadzadeh A, Ghorbanihaghjo A, Bahreini E, Rashtchizadeh N, Argani H, Alizadeh S.
    Retina; 2012 Apr; 32(4):658-66. PubMed ID: 22030834
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Serum paraoxonase and arylesterase activities in patients with lung cancer in a Turkish population.
    Elkiran ET, Mar N, Aygen B, Gursu F, Karaoglu A, Koca S.
    BMC Cancer; 2007 Mar 15; 7():48. PubMed ID: 17362500
    [Abstract] [Full Text] [Related]

  • 9. Paraoxonase/arylesterase ratio, PON1 192Q/R polymorphism and PON1 status are associated with increased risk of ischemic stroke.
    Can Demirdöğen B, Türkanoğlu A, Bek S, Sanisoğlu Y, Demirkaya S, Vural O, Arinç E, Adali O.
    Clin Biochem; 2008 Jan 15; 41(1-2):1-9. PubMed ID: 17920578
    [Abstract] [Full Text] [Related]

  • 10. Oxidation of apolipoprotein B-containing lipoproteins and serum paraoxonase/arylesterase activities in major depressive disorder.
    Sarandol A, Sarandol E, Eker SS, Karaagac EU, Hizli BZ, Dirican M, Kirli S.
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Aug 30; 30(6):1103-8. PubMed ID: 16716479
    [Abstract] [Full Text] [Related]

  • 11. Paraoxonase (PON1) polymorphism and activity as the determinants of sensitivity to organophosphates in human subjects.
    Sirivarasai J, Kaojarern S, Yoovathaworn K, Sura T.
    Chem Biol Interact; 2007 Jul 20; 168(3):184-92. PubMed ID: 17532308
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Paraoxonase 1 (PON1) 55 polymorphism, lipid profiles and psoriasis.
    Asefi M, Vaisi-Raygani A, Bahrehmand F, Kiani A, Rahimi Z, Nomani H, Ebrahimi A, Tavilani H, Pourmotabbed T.
    Br J Dermatol; 2012 Dec 20; 167(6):1279-86. PubMed ID: 22835076
    [Abstract] [Full Text] [Related]

  • 14. Paraoxonase polymorphism in northwestern Indians.
    Singh S, Verma M, Nain CK, Co L, Goel RC, Sharma BK.
    Int J Clin Pharmacol Ther; 1998 Oct 20; 36(10):545-8. PubMed ID: 9799059
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Discordance in human paraoxonase-1 gene between phenotypes and genotypes in chronic kidney disease.
    Paragh G, Seres I, Harangi M, Pocsai Z, Asztalos L, Locsey L, Szeles G, Kardos L, Varga E, Karpati I, Adany R.
    Nephron Clin Pract; 2009 Oct 20; 113(1):c46-53. PubMed ID: 19602899
    [Abstract] [Full Text] [Related]

  • 19. Oxidative status and serum PON1 activity in beta-thalassemia minor.
    Selek S, Aslan M, Horoz M, Gur M, Erel O.
    Clin Biochem; 2007 Mar 20; 40(5-6):287-91. PubMed ID: 17296173
    [Abstract] [Full Text] [Related]

  • 20. [Low paraoxonase and arylesterase plasma activities in Mexican patients with coronary artery disease].
    Gamboa R, Regalado JC, Huesca-Gómez C, Posadas-Romero C, Verdejo Paris J, Vargas-Alarcón G, Pérez-Méndez O.
    Arch Cardiol Mex; 2008 Mar 20; 78(4):360-8. PubMed ID: 19205543
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.